|
Jun 2
|
Sanofi to acquire Blueprint Medicines, Boeing upgrade
|
|
Jun 2
|
Sanofi to expand immunology offerings with Blueprint Medicines
|
|
Jun 2
|
Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal.
|
|
Jun 2
|
Sanofi to Acquire Blueprint Medicines for up to $9.5 Billion to Expand Immunology Portfolio
|
|
Jun 2
|
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover
|
|
Jun 2
|
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout
|
|
Jun 2
|
Sanofi to acquire Blueprint for up to $9.5B
|
|
Jun 2
|
5 Things to Know Before the Stock Market Opens
|
|
Jun 2
|
Trending tickers: Tesla, Palantir, Sanofi, Babcock and Indivior
|
|
Jun 2
|
Sanofi to Buy Blueprint Medicines for Up to $9.5 Billion in Boost to Pipeline
|
|
Jun 2
|
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
|
|
Jun 2
|
Sanofi to buy US biopharma group Blueprint for up to $9.5 billion
|
|
Apr 25
|
Blueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
|
|
Apr 24
|
Blueprint Medicines Corporation (BPMC): Among Takeover Rumors Hedge Funds Are Buying
|
|
Apr 21
|
3 High Growth Tech Stocks In The US Market
|
|
Mar 31
|
Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
|
|
Mar 30
|
Is Blueprint Medicines (BPMC) One of the Best Mid Cap Biotech Stocks to Buy?
|
|
Mar 13
|
Exploring High Growth Tech Stocks In The US Market March 2025
|
|
Feb 24
|
Blueprint Medicines Corporation (BPMC): Among the Oversold Biotech Stocks to Buy Now
|
|
Feb 15
|
Blueprint Medicines Full Year 2024 Earnings: EPS Beats Expectations
|